Beryllium Induces IL-2 and IFN-γ in Berylliosis

Journal of Immunology

Volumn 158, Issue 1, 1997, Pages 518-526

  Tinkle, Sally S ^a,b   Kittle, Lori A ^a   Schumacher, Beverly A ^a   Newman, Lee S ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERYLLIUM; BIOLOGICAL MARKER; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 7; MESSENGER RNA;

ADULT; ARTICLE; BERYLLIOSIS; BIOSYNTHESIS; BLOOD; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; LUNG LAVAGE; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; MIDDLE AGED; T LYMPHOCYTE;

ADULT; BERYLLIOSIS; BERYLLIUM; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-7; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0030639135     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. Semenzato, G., and C. Agostini. 1993. Immunology of sarcoidosis. In Interstitial Lung Diseuse, 2nd Ed. M. I. Schwarz and T. E. King, Jr., eds. Mosby Year Book, St. Louis, pp. 127-158.
2. Chensue, S. W., I. G. Otterness, G. I. Higashi, C. S. Forsch, and S. L. Kunkel. 1989. Monokine production by hypersensitivity (Schistosoma mansoni egg) and foreign body (Sephadex bead)-type granuloma macrophages: evidence for sequential production of IL-1 and tumor necrosis factor. J. Immunol. 142:1281.
3. Newman, L. S., K. Kreiss, T. E. King, Jr., S. Seay, and P. A. Campbell. 1989. Pathologic and immunologic alterations in early stages of beryllium disease: reexamination of disease definition and natural history. Am. Rev. Respir. Dis. 139: 1479.
4. Hunninghake, G. W., G. N. Bedell, D. C. Zavala, M. Monick, and M. Brady. 1983. Role of interleukin-2 release by lung T cells in active pulmonary sarcoidosis. Am. Rev. Respir. Dis. 128:634.
5. Van Snick, J. 1990. Interleukin-6: an overview. Ann. Rev. Immunol. 8:253.
6. Dinarello, C. A. 1992. Role of interleukin-1 in infectious diseases. Immunol. Rev. 127:119.
7. Farrar, M. A., and R. D. Schreiber. 1993. The molecular cell biology of interferon-γ and its receptor. Ann. Rev. Immunol. 11:571.
8. Pirmez, C., M. Yamamura, K. Ugemura, M. Paes-Oliviera, F. Conceicao-Silva, and R. L. Modlin. 1993. Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Invest. 91:1390.
9. Carvalho, E. M., O. Bacellar, C. Brownell, T. Regis, and R. L. Coffman. 1994. Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis. J. Immunol. 152:5949.
10. Mocci, S., and R. L. Coffman. 1995. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4. J. Immunol. 154:3779.
11. Chensue, S. W., K. S. Warmington, J. H. Ruth, P. Lincoln, and S. L. Kunkel. 1995. Cytokine function during mycobacterial and schistomsomal antigen-induced pulmonary granuloma formation: local and regional participation of IFN-γ, IL-10, and TNF. J. Immunol. 154:5969.
12. Smith, K. A., S. Gillis, P. B. Baker, D. McKenzie, and F. W. Ruscetti. 1979. T-cell growth factor-mediated T-cell proliferation. Ann. NY Acad. Sci. 332:423.
13. Robb, R. J. 1982. Human T-cell growth factor: purification and interaction with a cellular receptor. Lymphokine Res. 1:37.
14. Or, R., H. Renz, N. Terada, and E. W. Gelfand. 1992. 1L-4 and IL-2 promote human T-cell proliferation through symmetrical but independent pathways. Clin. Immunol. Immunopathol. 64:210.
15. Taniguchi, T., and Y. Minami. 1993. The IL-2/IL-2 receptor system: a current overview. Cell 73:5.
16. Reem, G. H., and N.-H. Yeh. 1984. Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes. Science 225:429.
17. Vilcek, J., D. Henriksen-Destefano, D. Seigel, A. Klion, R. J. Rob, and J. Le. 1985. Regulation of IFN-γ induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2. J. Immunol. 135:1851.
18. Kasahara, T., J. J. Hooks, S. F. Dougherty, and J. J. Oppenheim. 1983. Interleukin 2-mediated immune interferon (IFN-γ) production by human T cells and T cell subsets. J. Immunol. 130:1784.
19. Espinoza-Delgado, L. D. L. Longo, G. L. Gusella, and L. Varesio. 1992. Regulation of IL-2 receptor subunit genes in human monocytes: differential effects of IL-2 and IFN-γ. J. Immunol. 149:2961.
20. Sica, A., T.-H. Tan, N. Rice, M. Kretzschmar, P. Ghosh, and H. A. Young. 1992. The c-rel protooncogene product c-Rel hut not NF-κB binds to the intronic region of the human interferon-γ at a site related to an interferon-stimulatable response element. Proc. Natl. Acad. Sci. USA 89:1740.
21. Vilcek, J., and I. C. Oliveira. 1994. Recent progress in the elucidation of interferon-gamma actions: molecular biology and biological functions. Int. Arch. Allergy Immunol. 104:311.
22. Abehsira-Amar, O., M. Gibert, M. Joliy, J. Theze, and D. L. Jankovic. 1992. IL-4 plays a dominant role in the differential development of Th0 into Th1 and Th2 cells. J. Immunol. 148:3820.
23. Parronchi, P., M. De Carli, R. Manetti, C. Simonelli, S. Sampognaro, M.-P. Piccinni, D. Macchia, E. Maggi, G. Del Pretre, and S. Romagnani. 1992. IL-4 and IFN (α and γ) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J. Immunol. 149:2977.
24. Most, J., H. P. Neumayer, and M. P. Dierich. 1990. Cytokine-induced generation of multi-nucleated giant cells in vitro requires interferon-γ and expression of LEA-1. Eur. J. Immunol. 20:1661.
25. Agusti, C., A. Xaubet, R. Arriols, A. Marin, J. M. Montserrat, and A. Agusti-Vidal. 1987. Multi-nuclear giant cells in bronchoalveolar lavage in interstitial lung diseases. Respiration 51:307.
26. Rossman, M. D., J. A. Kern, J. A. Elias, M. R. Cullen, P. E. Epstein, O. P. Preuss, T. N. Markham, and R. P. Daniele. 1988. Proliferative response of bronchoalveolar lymphocytes to beryllium: a test for chronic beryllium disease. Ann. Intern. Med. 108:687.
27. Saltini, C., K. Winestock, M. Kirby, P. Pinkston, and R. G. Crystal. 1989. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N. Engl. J. Med. 320:1103.
28. Newman, L. S., M. M. Mroz, B. Schumacher, E. Daniloff, and K. Kreiss. 1992. Beryllium sensitization precedes chronic beryllium disease. Am. Rev. Respir. Dis. 145(Suppl.):A324.
29. Newman, L. S., C. Bobka, B. Schumacher, E. Daniloff, B. Zhen, M. M. Mroz, and T. E. King. 1994. Compartmentalized immune response reflects clinical severity of beryllium disease. Am. J. Respir. Crit. Care Med. 150:135.
30. Dokter, W. H. A., S. J. Sierdsema, M. T. Esselink, M. R. Halie, and E. Vellenga. 1994. Interleukin-4 mRNA and protein in activated human T cells are enhanced by interleukin-7. Exp. Hematol. 22:74.
31. Borger, P., H. F. Kauffman, D. S. Postma, and E. Vellenga. 1996. IL-7 differentially modulates the expression of IFN-γ and IL-4 in activated human T lymphocytes by transcriptional and post-transcriptional mechanisms. J. Immunol. 156:1333.
32. Epstein, P. E., J. H. Dauber, M. D. Rossman, and R. P. Daniele. 1982. Bronchalveolar lavage in a patient with chronic berylliosis: evidence for hypersensitivity pneumonitis. Ann. Intern. Med. 97:213.
33. Mroz, M. M., K. Kreiss, D. C. Lezotte, P. A. Campbell, and L. S. Newman. 1991. Re-examination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J. Allergy Clin. Immunol. 88:54.
34. Bost, T. W., D. W. H. Riches, B. Schumacher, P. C. Carré, T. Z. Kahn, J. A. B. Martinez, and L. S. Newman. 1994. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for TNF-α and IL-6 but not IL-1β. Am. J. Respir. Cell Mol. Biol. 10:506.
35. Watters, L. C., M. I. Schwarz, R. M. Cherniack, J. A. Waldron, T. L. Dunn, R. Stanford, and T. E. King. 1987. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am. Rev. Respir. Dis. 135:696.
36. International Labour Organization. 1980. International Labour Organization: guidelines for the use of ILO international classification of radiographs of pneumoconioses. In International Labour Office (Occupational Safety and Health Series, No. 22 [REV]). International Labour Office, Geneva, Switzerland.
37. Morris, A. H., R. E. Kanner, R. O. Crapo, and R. M. Gardner. 1984. Clinical Pulmonary Function Testing: A Manual of Uniform Laboratory Procedures, 2nd Ed. Intermountain Thoracic Society, Salt Lake City, pp. 154-155.
38. Ogilvie, C. M., R. E. Forster, W. S. Blakemore, and J. W. Morton. 1956. A standardized breath-holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J. Clin. Invest. 36:1.
39. Crapo, R. O., and A. H. Morris. 1981. Standarized single breath normal values for carbon monoxide dissusing capacity. Am. Rev. Respir. Dis. 123:185.
40. Pappas, G. P., and L. S. Newman. 1993. Early pulmonary physiologic abnormalities in beryllium disease. Am. Rev. Respir. Dis. 148:661.
41. Goodman, H. M., and R. J. MacDonald. 1979. Cloning of hormone genes from a mixture of cDNA molecules. In Methods in Enzymology: Recombinant DNA, Vol. 68. R. Wu, ed. Academic Press, New York, pp. 75-90.
42. Winer, B. J. 1971. Statistical Principles in Experimental Design, 2nd Ed. McGraw-Hill, New York, pp. 261-305.
43. Diggle, P. J-. K. Y. Liana, and S. L. Zeger. 1994. Analysis of Longitudional Data, 1st Ed. Clarendon Press, Oxford, p. 56.
44. Snedecor, W. G., and W. G. Cochran. 1989. Statistical Methods, 8th Ed. Iowa State University, Ames, pp. 142-144, 193-194, 227.
45. Danzer, S. G., H. Kirchner, and L. Rink. 1994. Cytokine interactions in human mixed lymphocyte culture. Transplantation 57:1638.
46. Pforte, A., A. Brunner, P. Gais, G. Burger, G. Breyer, M. Strobel, K. Haussinger, and H. W. Ziegler-Heitbrock. 1993. Concomitant modulation of serum-soluble interleukin-2 receptor and alveolar macrophage interleukin-2 receptor in sarcoidosis. Am. Rev. Respir. Dis. 147:717.
47. Hol, B. E., R. Q. Hintzen, R. A. Van Lier, C. Alberts, T. A. Out, and H. M. Jansen. 1993. Soluble and cellular markers of T cell activation in patients with pulmonary sarcoidosis. Am. Rev. Respir. Dis. 148:643.
48. Pforte, A., A. Brunner, P. Gais, M. Strobel, G. Burger, G. Breyer, K. Haussinger, and L. Ziegler-Heitbrock. 1994. Increased levels of soluble serum interleukin-2 receptor in extrinsic allergic alveolitis correlate with interleukin-2 receptor expression on alveolar macrophage. J. Allergy Clin. Immunol. 94:1057.
49. Oishi, M., M. Johno, T. Ono, and M. Honda. 1994. Differences in IL-2 receptor levels between mycosis fungoides and cutaneous type adult T-cell leukemia/ lymphoma in the early stages of the disease. J. Invest. Dermatol. 102:710.
50. Kamihira, S., S. Atogami, H. Sohda, S. Momita, Y. Yamada, and M. Tomonaga. 1994. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia. Cancer 73:2753.
51. Ward, M. M., E. Pyun, and D. S. Pisetsky. 1994. Serial measurement of serum interleukin-2 receptor levels in patients with rheumatoid arthritis: limited evidence for a role of T cell activation in clinical exacerbations. Clin. Immunol. Immunopathol. 73:296.
52. Carotti, M., F. Salaffi, G. F. Ferraccioli, M. C. Binci, A. Sartini, and C. Cervini. 1994. Soluble interleukin-2 receptor in sera and synovial fluids of rheumatoid patients: correlations with disease activity. Rheumatol. Int. 14:47.
53. Steiner, G., A. Studnicka-Benke, O. Witzmann, E. Hofler, and J. Smolen. 1995. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis, and osteoarthritis. J. Rheumatol. 22:406.
54. Minami, Y., T. Kono, T. Miyazaki, and T. Taniguchi. 1993. The IL-2 receptor complex: its structure, function, and target genes. Annu. Rev. Immunol. 11:245.
55. Espinoza-Delgado, I., M. C. Bosco, T. Musso, G. L. Gussella, D. L. Longo, and L. Varesio. 1995. Interieukin-2 and human monocyte activation. J. Leukocyte Biol. 57:13.
56. Grabstein, K., S. Dower, S. Gillis, D. Urdal, and A. Larsen. 1986. Expression of interleukin-2, interferon-γ, and the IL-2 receptor by human peripheral blood lymphocytes. J. Immunol. 136:4503.
57. Mueller-Quernheim, J., S. Pfiefer, D. Mannel, J. Strausz, and R. Ferlinz. 1992. Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am. Rev. Respir. Dis. 145:187.
58. + T cell subset. J. Clin. Invest. 77:1962.
59. Robinson, B. W., T. L. McLemore, and R. G. Crystal. 1985. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J. Clin. Invest. 75:1488.
60. Fan, J., H. Z. Bass, and J. L. Fahey. 1993. Elevated IFN-γ and decreased IL-2 gene expression are associated with HIV infection. J. Immunol. 151:5031.
61. Wynn, T. A., I. Eltoum, I. P. Oswald, A. W. Cheever, and A. Sher. 1994. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 179:1551.
62. Efrat, S., S. Pilo, and R. Kaempfer. 1982. Kinetics of induction and molecular size of mRNAs encoding human interleukin 2 and γ-interferon. Nature 297:236.
63. Wiskocil, R., A. Weiss, J. Imboden, R. Kamin-Lewis, and J. Stobo. 1985. Activition of a human T cell line: a two-stimulus requirement in the pretranslational events involved in the coordinate expression of interleukin 2 and γ-interferon genes. J. Immunol. 134:1599.
64. Salvaggio, J. E., M. H. Flax, and S. Leskowitz. 1965. Studies in immunzation: III. The use of beryllium as a granuloma-producing agent in Freund's adjuvant. J. Immunol. 95:846.
65. Unanue, E. R., B. A. Askonas, and A. C. Allison. 1969. A role of macrophages in the stimulation of immune responses by adjuvants. J. Immunol. 103:71.
66. Unanue, E. R., J.-M. Kiely, and J. Calderon. 1976. The modulation of lymphocyte function by molecules secreted by macrophages: II. Conditions leading to increased secretion. J. Exp. Med. 144:155.
67. Behbehani, K., D. I. Beller, and E. R. Unanue. 1985. The effects of beryllium and other adjuvants on Io expression by macrophages. J. Immunol. 134:2047.
68. Denham, S., and J. G. Hall. 1988. Studies on the adjuvant action of beryllium: III. The activity in the plasma of lymph efferent from nodes stimulated with beryllium. Immunology 64:341.
69. Thomas, M., and W. N. Aldridge. 1966. The inhibition of enzymes by beryllium. Biochem. J. 98:94.
70. Reiner, E. 1971. Binding of beryllium to proteins. In Symposium Mechanism of Toxicity. W. N. Aldridge, ed. St. Martin's Press, New York, pp. 111-125.
71. Sirover, M. A., and L. A. Loeb. 1976. Metal-induced infidelity during DNA synthesis. Proc. Natl. Acad. Sci. USA 73:2331.
72. Parker, V. H., and C. Stevens. 1979. Binding of beryllium to nuclear acidic proteins. Chem. Biol. Interact. 26:167.
73. Kaser, M. R., M. G. Ord, and L. A. Stocken. 1980. The effects of beryllium on histone phosphorylation in liver. Biochem. Int. 1:148.
74. Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospísil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trinchieri. 1991. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869.
75. Chan, S. H., M. Kobayashi, D. Santoli, B. Perussia, and G. Trinchieri. 1992. Mechanisms of IFN-γ induction by natural killer cell stimulatory factor (NKSF/ IL-12): role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J. Immunol. 148:92.
76. Bertagnolli, M. M., B.-Y. Lin, D. Young, and S. H. Herrmann. 1992. IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J. Immunol. 149:3778.
77. Manetti, R., F. Gerosa, M. G. Giudizi, R. Biagiotti, P. Parronchi, M.-P. Piccinni, S. Sampognaro, E. Maggi, S. Romagnani, and G. Trinchieri. 1994. Interleukin 12 induces stable priming for interferon γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones. J. Exp. Med. 179:1273.
78. Peleman, R., J. Wu, C. Fargeas, and G. Delespesse. 1989. Recombinant interluekin 4 suppresses the production of interferon γ by human mononuclear cells. J. Exp. Med. 170:1751.
79. Vercelli, D., H. H. Jabara, R. P. Lauener, and R. S. Geha. 1990. IL-4 inhibits the synthesis of IFN-γ and induces the synthesis of IgE in human mixed lymphocyte cultures. J. Immunol. 144:570.
80. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444.
81. Taga, T., and T. Kishimoto. 1995. Signaling mechanisms through cytokine receptors that share signal transducing receptor components. Curr. Opin. Immunol. 7:17.
82. Lamer, A. C., E. F. Petricoin, Y. Nakagawa, and D. S. Finbloom. 1993. IL-4 attenuates the transcriptional activation of both IFN-α-and IFN-γ-induced cellular gene expression in monocytes and monocytic cell lines. J. Immunol. 150:1944.
83. Schlaak, J. F., E. Hermann, H. Gallati, K.-H. Meyer Zum Büschenfelde, and B. Fleischer. 1994, Differential effects of IL-10 on proliferation and cytokine production of human γ/δ and α/β T cells. Scand. J. Immunol. 39:209.
84. Yamamura, M., K. Uyemura, R. J. Deans, K. Weinberg, T. H. Rea, B. R. Bloom, and R. L. Modlin. 1991. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254:277.
85. Nelson, D. L., L. A. Rubin, C. C. Kurman, M. E. Fritz, and B. Boutin. 1986. An analysis of the cellular requirements for the production of soluble interleukin-2 receptor in vitro. J. Clin. Immunol. 6:114.
86. Lai, K. N., J. C. K. Leung, C. C. Chow, and C. S. Cockram. 1989. T lymphocyte activation in euthyroid Graves' ophthalmopathy: soluble interleukin 2 receptor release, cellular interleukin 2 receptor expression and interleukin 2 production. Acta Endocrinol. 120:602.
87. Silverstein, E., L. P. Pertschuk, and J. Friedland. 1979. Immunofluorescent localization of angiotensin-converting enzyme in epithelioid and giant cells of sarcoidosis granulomas. Proc. Natl. Acad. Sci. USA 76:6646.
88. Weinstock, J. V., and A. M. Blum. 1985. Effects of granuloma modulation induced by regulatory-T-lymphocyte activity on angiotensin II/III production by granuloma macrophages in murine Schistosomiasis mansoni. Cell. Immunol. 94:558.
89. Inoue, Y. 1988. Direct radioimmunoassay of angiotensin-converting enzyme in serum and bronchoalveolar lavage fluid from patients with pulmonary diseases. Jpn. J. Thoracic Soc. 26:129.
90. Hurowitz, J., F. Kueppers, and S. Rosen. 1981. Angiotensen-converting enzyme concentrations in rabbits with talc-induced pulmonary granulomas. Am. Rev. Respir. Dis. 124:306.
91. Weinstock, J. V., and A. M. Blum. 1983. Isolated liver granulomas of murine Schistosoma mansoni contain components of the angiotensin system. J. Immunol. 131:2529.
92. Lieberman, J., M. Krauthammer, and A. Sastre. 1986. Serum angiotensin-converting enzyme in rabbits with and without pulmonary granulomatosis: granulomatosis induced with complete Freund's adjuvant or BCG. Sarcoidosis 3:60.